# FDA Inspection 1123952 - Belkis Delgado, M.D. - May 29, 2020

Source: https://www.keypedia.com/records/fda_inspections/belkis-delgado-md/ea415529-3d8a-4f94-8fbd-a844518905fb
Source feed: FDA_Inspections

> FDA Inspection 1123952 for Belkis Delgado, M.D. on May 29, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1123952
- Company Name: Belkis Delgado, M.D.
- Inspection Date: 2020-05-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1251195 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/belkis-delgado-md/c3ae7e00-4405-40f6-8af2-89a1d4037467)
- [FDA Inspection 1251195 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/belkis-delgado-md/22fb2f2c-f0f5-45d7-a96a-0a23d870b5c9)
- [FDA Inspection 1062840 - 2018-08-09](https://www.keypedia.com/records/fda_inspections/belkis-delgado-md/744e27e5-913c-4f24-9d92-67f42e7a694b)

Company: https://www.keypedia.com/companies/belkis-delgado-md/82f5b245-ed05-4e45-9f8a-c61c47adaa01

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c